Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators

V Wee Yong1, Rana K Zabad, Smriti Agrawal

  • 1Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. vyong@ucalgary.ca

Insights

Matrix metalloproteinases (MMPs) contribute to multiple sclerosis (MS) pathology by aiding leukocyte migration into the central nervous system. Interferon-beta and minocycline show potential therapeutic effects by modulating MMPs in MS and EAE models.

Area of Science:

  • Neuroimmunology
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix degradation.
  • Elevated MMP levels are observed in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE).
  • MMPs play a critical role in the breakdown of the blood-brain barrier, facilitating leukocyte infiltration into the central nervous system (CNS).

Purpose of the Study:

  • To review the role of MMPs in the pathology of multiple sclerosis (MS).
  • To examine the impact of interferon-beta, a common MS therapeutic, on MMP expression.
  • To discuss the therapeutic potential of minocycline, an MMP inhibitor, for MS treatment.

Main Methods:

  • Literature review of studies on MMPs in MS and EAE.
  • Analysis of research on the effects of interferon-beta on MMPs.
  • Evaluation of studies investigating minocycline's mechanism of action and therapeutic efficacy.

Main Results:

  • Upregulation of specific MMP members contributes to MS pathogenesis.
  • MMPs are crucial for leukocyte transmigration into the CNS in MS and EAE.
  • Interferon-beta influences MMP expression in the context of MS.
  • Minocycline exhibits MMP inhibitory activity and may offer therapeutic benefits in MS through various mechanisms.

Conclusions:

  • MMPs are key players in the inflammatory and neurodegenerative processes of MS.
  • Modulating MMP activity presents a potential therapeutic strategy for MS.
  • Interferon-beta and minocycline warrant further investigation for their roles in managing MS, considering their effects on MMPs.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...